You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...

Bezuclastinib's upcoming data in July 2025 could be a game-changer for COGT, offering a lucrative investment opportunity. See ...

These cheap shares may be takeover targets in 2025, and as such, potentially offer shareholders the chance to earn outsized returns.

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

Patrick R. O'Neil, Executive Vice President, Chief Legal Officer, and General Counsel at Ionis Pharmaceuticals Inc ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

As global markets show resilience with cooling inflation and robust bank earnings propelling U.S. stocks higher, investors are keenly observing how these dynamics influence their portfolios. In this ...

Here are some of the major companies whose stocks moved on the week’s news.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...

Sun Pharmaceutical Industries Ltd is set to release its Q3 earnings for the quarter ending December 31, 2024, on Friday, ...